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Synovial joint arthritis is a leading cause of disability with treatment options being remarkably limited.  
The synovial membrane lines the joint space, producing synovial fluid to facilitate joint lubrication, 
and is a tissue richly innervated with nociceptors. It also acts as a key gateway between the avascular 
joint space and the circulatory system. Therefore, as we work towards new treatments that target 
joint disease, building an understanding of how the cells within the synovial membrane are regulated 
is of critical importance.  Sadly, whilst we do know a fair amount about the composition and function 
of the synovium, we still have a lot to learn about how to control the important fibroblast-like 
synoviocytes within.  The latest study by Kondo et al 2018 goes some way to address this by developing 
a fundamentally important working hypothesis for control of synoviocytes that links, purinergic and 
histamine receptor activation to intracellular calcium mobilisation and cell membrane 
hyperpolarisation.  
 
Kondo et al 2018 use an unusually well laden tool bag of cell physiological techniques to put this 
schema together; with a panel of 19 qPCR primer pairs, intracellular Ca2+ imaging, flash photolysis of 
caged ip3 and of course patch-clamp electrophysiology.  Two separate inflammatory mediators, ATP 
and histamine both act in parallel to trigger PLC activation, IP3 elevation, thence Ca2+ elevation and 
activation of a potassium conductance.  A particular strength is that the entire model is built in human 
fibroblast-like synoviocytes bringing two strengths over previous models, which have tended to be 
based on either healthy rodent joints or rheumatic human joints. Firstly, in the absence of specific 
markers for synovial fibroblasts, the use of tissue from a larger organism ensures that there can be 
greater confidence that the fibroblastic population being cultured is chiefly of synovial origin. 
Secondly, it is of course vital to work-out what happens in a rheumatic joint, but surely the ideal 
starting models would be the normal “physiological” system in a healthy synovium. 
 
How does Kondo et al 2018’s new working hypothesis fit with the existing literature? Rather well it 
turns out. It is known that during inflammation, histamine is released and ATP levels also increase as 
the nucleotide is released, typically, through activated pannexin channels.  This paper shows, 
moderate levels of pannexin expression (PANX1 by qPCR), together with that of a connexin (CX43), 
which could hypothetically form an alternative ATP release conduit. There was also high expression of 
both intermediate (KCa3.1) and large (BK/KCa1.1) Ca2+-activated potassium channels.  Encouragingly for 
those working with other model systems these ion channels were identified in both rheumatoid 
arthritis-derived and rodent model FLS studies (Friebel et al., 2014; Hu et al., 2012; Tanner et al., 2015).  
The other most highly expressed ion channels (again identified by qPCR) were KCNK2, ANO6, ANO10 
and KCNK6.  KCNK2/6 are members of the twin-pore potassium channel family and are particularly 
thought of as molecular sensors, whereas the ANO (anoctamin) channels are members of the large 
chloride channel family. The family is relatively understudied compared to potassium channels, but 
ANO6 (TMEM16F) is, interestingly, thought to be a Ca2+-activated chloride channel likely, therefore, 
to be activated in parallel to Ca2+-activated potassium channels. 
Where next?  Well this paper documents the all-important control of synoviocytes rather than how 
that system will practically influence joint function or even joint pain, but it does not take much 
extrapolation to contextualise this.  Activation of Ca2+-activated potassium channels somehow drives 
invasiveness of synoviocytes and progression of arthritis in both human and rodent RA models by 
increasing invasiveness, proliferation and production of both inflammatory mediators and catabolic 
enzymes (Friebel et al., 2014; Hu et al., 2012; Tanner et al., 2015). But that does leave further 
questions; how does activation of KCa and hyperpolarisation of a cell drive its activation?  Is it that 
hyperpolarisation puts the cell into an active state per se …or is it an analogous mechanism to that we 
modelled mathematically in neurones where hyperpolarisation serves to draw extracellular Ca2+ into 
the cell (by increasing the driving force for Ca2+ entry through a non-voltage gated Ca2+ entry pathway 
(Feetham et al., 2015)).  …and why, physiologically speaking, would activation of FLS even cause 
progression of disease and pain?  Or is it the other way around; does activation of FLS result from 
disease in a compensatory physiological “attempt” to restore joint homeostasis.  Investigation of all 
these questions will now be a far more realistic possibility in the light of the new Kondo et al 2018 
“working hypothesis” model. 
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